Traders should view this coordinated insider buying as a positive signal, particularly given the material dollar amount and open-market nature of the trades. Consider positioning ahead of potential positive catalysts, such as clinical updates or earnings.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Feb 27 $135.02entry
- T+1 · 9mo ago −1.78%α −1.84% · $132.61
- T+5 · 9mo ago −0.47%α +1.52% · $134.39
- T+20 · 8mo ago −16.78%α −9.22% · $112.37
- T+60 · 6mo ago −12.91%α −22.30% · $117.59
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two insiders at Palvella Therapeutics, Inc. (PVLA) made open-market purchases totaling $800,000 within the past week, buying shares at $125 per share. The transactions represent a coordinated buying signal from corporate insiders, which may reflect confidence in the company's near-term prospects.
Key Financial Metrics
Key Facts
- George M. Jenkins purchased 4,000 shares at $125 per share for a total of $500,000 in an open-market transaction.
- Elaine J. Heron purchased 2,400 shares at $125 per share for a total of $300,000 in an open-market transaction.
- Both transactions occurred on 2026-02-27 and were executed in the open market (Form 4 code 'P').
- Total value of the insider cluster: $800,000.
- Cluster represents 0.05% of the company's $1.6B market cap.
Financial Impact
$800,000 in insider buying at $125 per share
Risk Factors
- The total value ($800K) is still relatively small compared to the $1.6B market cap, limiting broad market impact.
- No additional context (e.g., upcoming earnings, clinical data) is provided to confirm the trigger for the buying.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-PVLA-1772456485987 |
Track record
36 reports on PVLA
4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +35.07% at T+60 after the May 15, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $145.21 Now $144.60 −0.42% settles Dec 16
- Nov 10, 20266d ago 144 Neutral 5/10 Entry $163.94 Now $144.60 −11.80% settles Dec 10
- Nov 5, 202611d ago 8-K Bullish 7/10 Entry $156.85 Now $144.60 −7.81% settles Dec 4
- Nov 5, 202611d ago Press Release Neutral 6/10 No price data
- Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $152.93 Now $144.60 −5.45% settles Dec 2
- Oct 28, 202619d ago SC 13G/A Neutral 3/10 Entry $147.47 Now $144.60 −1.95% settles Nov 25
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $147.47 Now $144.60 −1.95% settles Nov 25
- Oct 28, 202619d ago Press Release Bullish 7/10 Entry $147.47 Now $144.60 −1.95% settles Nov 25
- Oct 23, 202624d ago Insider Cluster Neutral 2/10 Entry $126.23 Now $144.60 +14.55% settles Nov 23
- Oct 15, 20264w ago Press Release Neutral 4/10 Entry $127.34 to $153.18 Now $144.60 +13.55% ▲ +20.29% +22.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers